GANX — GAIN THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in GAIN THERAPEUTICS INC (GANX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 38,537 — — 0.00% $68K $1.77
% of Fund (quarterly)    GANX price (monthly, adj. close)

Other funds also holding GANX

As of 2025 Q4 — sorted by position size

DME Capital Management, LP 0.06% BENEDICT FINANCIAL ADVISORS INC 3Y 7Y 0.03% Oliver Luxxe Assets LLC 3Y 7Y 0.01% PRELUDE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.01% MARSHALL WACE, LLP 3Y 7Y 0.0% Cambridge Investment Research Advisors, Inc. 3Y 7Y 0.0% Sandhill Capital Partners LLC 3Y 7Y 0.0% Lighthouse Investment Partners, LLC 3Y 0.0% Cresset Asset Management, LLC 3Y 7Y 0.0%
← Back to Squarepoint Ops LLC Holdings